Business News • MarketWire • Amedica Announces Positive Scientific Data and Re-files FDA Submission |
Amedica Announces Positive Scientific Data and Re-files FDA Submission |
|
|
Amedica Announces Positive Scientific Data and Re-files FDA Submission
SALT LAKE CITY, UT--(Marketwired - Dec 19, 2016) - Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, announced encouraging results from a recent study showing rapid bone growth into porous silicon nitride. Explants of the company's porous silicon nitride from a large-animal model demonstrated bone healing into the material just four weeks after implantation. "We anticipate these preliminary findings will be confirmed with additional retrieval data in the near future. The porous silicon nitride sample used in this study is the cancellous-structured ceramic (CsC) used in the center of our composite cervical implants that were the subject of recent FDA communications," said Dr. B. Sonny Bal, CEO and President of Amedica Corporation.
View More : http://www.marketwired.com/mw/release.do?id=2184226&sourceType=3
|
|
|